SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- NuevocorNuevocor, a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place in San Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will also be giving an oral presentation on new pre-clinical data for its LMNA cardiac gene therapy programme at the Keystone Symposium on Heart Development and Disease, taking place in Santa Fe, NM, USA from February 12 to 15, 2023. Details of the presentations are as follows:
Date: Tuesday, January 10, 2023
Location: Hilton San Francisco Union Square, Franciscan B (Ballroom Level)
Presenter: Yann Chong Tan, PhD, Founder and CEO, Nuevocor Keystone Symposia on Heart Development and Disease: From Genes to Cures
Date: Tuesday, February 14, 2023
Location: Eldorado Hotel, Santa Fe
Title: Targeting the LINC Complex with AAV Gene Therapy Extends Lifespan and Preserves Cardiac Function in a Mouse Model of LMNA Dilated Cardiomyopathy Presenter: Yin Loon Lee, PhD, Founder and Senior Director, Biology, Nuevocor For more information on the meetings, please visit the respective conference websites.